<?xml version="1.0"?>
<rss version="2.0" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:media="http://search.yahoo.com/mrss/" xmlns:yt="http://gdata.youtube.com/schemas/2007" xmlns:atom="http://www.w3.org/2005/Atom">
   <channel>
      <title>SDBN News</title>
      <description>Pipes Output</description>
      <link>http://pipes.yahoo.com/pipes/pipe.info?_id=47c9553eec56fd06090bdeddea677bc5</link>
      <atom:link rel="next" href="http://pipes.yahoo.com/pipes/pipe.run?_id=47c9553eec56fd06090bdeddea677bc5&amp;_render=rss&amp;page=2"/>
      <pubDate>Thu, 01 Oct 2015 22:39:05 +0000</pubDate>
      <generator>http://pipes.yahoo.com/pipes/</generator>
      <item>
         <title>Elcelyx Raises $40M, Begins Late-Stage Trial of New Diabetes Drug</title>
         <link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/qxITw8awcmI/</link>
         <guid isPermaLink="false">http://www.xconomy.com/?p=310120</guid>
         <pubDate>Thu, 01 Oct 2015 12:34:32 +0000</pubDate>
         <content:encoded><![CDATA[San Diego-based Elcelyx Therapeutics said today it has secured $40 million in a Series E financing&#8212;its biggest ever&#8212;after receiving official guidance from the FDA for late-stage trials of...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/qxITw8awcmI" height="1" width="1" alt=""/>]]></content:encoded>
      </item>
      <item>
         <title>SoCal's Elcelyx Therapeutics Reels in $40 Million</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=393364&amp;full=1</link>
         <description>&lt;font&gt;&lt;b&gt;Elcelyx Therapeutics Announces $40 Million Series E Financing&lt;/font&gt;&lt;/b&gt;&lt;br&gt;&lt;br&gt;&lt;b&gt;Company Enrolling Phase 2b Trial of Metformin Delayed Release for Type 2 Diabetes&lt;/b&gt;&lt;br&gt;&lt;p&gt;SAN DIEGO, Oct. 1, 2015 /PRNewswire/ -- Elcelyx Therapeutics has raised $40 million in a Series E financing following receipt of guidance from the U.S. Food and Drug Administration regarding the late...</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Thu, 01 Oct 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Orexigen Announces Submission Of Contrave New Drug Application In South Korea</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=393399&amp;full=1</link>
         <description>&lt;div&gt;&lt;p&gt;&lt;span&gt;SAN DIEGO&lt;/span&gt;, &lt;span&gt;Oct. 1, 2015&lt;/span&gt; /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced that Kwang Dong Pharmaceutical Company, Ltd., has filed a New Drug Application with the Ministry of Food and Drug Safety (MFDS) in &lt;span&gt;South Korea&lt;/span&gt; for Contrave&lt;sup&gt;&lt;/sup&gt; (naltrexone...&lt;/div&gt;</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Thu, 01 Oct 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>AntiCancer Announces New Technology For Growing Hair In Long-Term Culture</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=393544&amp;full=1</link>
         <description>&lt;div&gt;&lt;p&gt;SAN DIEGO--(&lt;a rel=&quot;nofollow&quot;&gt;BUSINESS WIRE&lt;/a&gt;)--&lt;a rel=&quot;nofollow&quot;&gt;AntiCancer       Inc.&lt;/a&gt; has announced...&lt;/div&gt;</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Thu, 01 Oct 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Apricus Biosciences And Ferring Pharmaceuticals Sign Exclusive Distribution Agreement To Market Topical Erectile Dysfunction Cream Vitaros In Latin American Countries</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=393425&amp;full=1</link>
         <description>&lt;p&gt;SAN DIEGO, Oct. 1, 2015 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that it has signed an exclusive distribution agreement with Ferring Pharmaceuticals (&quot;Ferring&quot;) to market Vitaros...</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Thu, 01 Oct 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>The Medicines Company Announces BARDA Exercises Next Option On Contract For Support Of The Development Of CARBAVANCE (Meropenem/RPX7009) For Drug-Resistant Gram-Negative Pathogens</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=393572&amp;full=1</link>
         <description>PARSIPPANY, N.J. &amp; SAN DIEGO--(BUSINESS WIRE)--The Medicines Company (NASDAQ:MDCO) today announced that Rempex Pharmaceuticals, a wholly owned subsidiary, has been awarded the next option on a contract by the Biomedical Advanced Research and Development Authority (BARDA) to support the development of CARBAVANCE (meropenem/RPX7009). CARBAVANCE is the combination of a carbapenem antibiotic with a novel...</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Thu, 01 Oct 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Illumina Expands World???s Largest Genomics Analysis Platform And Adds To Open Source Initiative</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=393573&amp;full=1</link>
         <description>SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ: ILMN) today announced several new additions to BaseSpacethe worlds largest and most comprehensive cloud computing environmentwith the launch of BaseSpace Professional and Enterprise Editions, fully integrated Laboratory Information Management System (LIMS) solutions and advanced infrastructure upgrades.&lt;br&gt;&lt;br&gt;Help employers find you! Check out...</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Thu, 01 Oct 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Neurocrine Biosciences Announces The Appointment Of To Its Board Of Directors</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=393386&amp;full=1</link>
         <description>&lt;div&gt;&lt;p&gt;&lt;span&gt;SAN DIEGO&lt;/span&gt;, &lt;span&gt;Sept. 30, 2015&lt;/span&gt; /PRNewswire/ --Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that it has appointed &lt;span&gt;George J. Morrow&lt;/span&gt; to its Board of Directors. Mr. Morrow has over three decades of global pharmaceutical commercial operations leadership experience with Amgen...&lt;/div&gt;</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Thu, 01 Oct 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Mo Bio Laboratories, Inc. Launches New, Redesigned Website</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=393464&amp;full=1</link>
         <description>&lt;div&gt;&lt;p&gt;&lt;span&gt;CARLSBAD, Calif.&lt;/span&gt;, &lt;span&gt;Oct. 1, 2015&lt;/span&gt; /PRNewswire/ -- MO BIO Laboratories, Inc., the leader in soil, stool and microbial nucleic acid purification, announces the launch of the redesign of its website, &lt;a rel=&quot;nofollow&quot;&gt;www.mobio.com&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Thu, 01 Oct 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>My Déjà vu Moment in Genomics: Why We Need Industry Standards Now</title>
         <link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/deEfgZh57Fo/</link>
         <guid isPermaLink="false">http://www.xconomy.com/?p=309468</guid>
         <pubDate>Tue, 29 Sep 2015 09:40:18 +0000</pubDate>
         <content:encoded><![CDATA[I am a serial entrepreneur who has spent the past couple of decades advancing the front lines of technology in digital healthcare, wireless communications, and semiconductor industries. And I’ve been...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/deEfgZh57Fo" height="1" width="1" alt=""/>]]></content:encoded>
      </item>
      <item>
         <title>Dunsire, Forum Search For Answers After FDA Halts Alzheimer’s Trial</title>
         <link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/PFDWRlR8hEc/</link>
         <guid isPermaLink="false">http://www.xconomy.com/?p=309920</guid>
         <pubDate>Tue, 29 Sep 2015 07:00:09 +0000</pubDate>
         <content:encoded><![CDATA[A litany of promising therapies for Alzheimer’s disease have crashed and burned in late-stage testing. So it was an ominous sign when the FDA recently placed a clinical hold on a big Phase 3 trial...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/PFDWRlR8hEc" height="1" width="1" alt=""/>]]></content:encoded>
      </item>
      <item>
         <title>West Coast Biotech Roundup: Gilead, Conatus, Exelixis, and More</title>
         <link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/s-cR0ZhnefQ/</link>
         <guid isPermaLink="false">http://www.xconomy.com/?p=309753</guid>
         <pubDate>Fri, 25 Sep 2015 14:54:31 +0000</pubDate>
         <content:encoded><![CDATA[Those of you who thought that DreamWorks’ Shrek franchise ended in 2010 with Shrek Ever After may have been surprised when a new installment played out over the past week with the big green ogre...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/s-cR0ZhnefQ" height="1" width="1" alt=""/>]]></content:encoded>
      </item>
      <item>
         <title>Shkreli Implodes And Provides Hillary A Perfect Medicare Moment</title>
         <link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/LhCLmEimKRg/</link>
         <guid isPermaLink="false">http://www.xconomy.com/?p=309656</guid>
         <pubDate>Wed, 23 Sep 2015 22:46:31 +0000</pubDate>
         <content:encoded><![CDATA[It was already a good political time for Hillary Clinton to unveil her plan to control the cost of prescription drugs. Martin Shkreli made it perfect. As you&#8217;ve probably heard by now, the...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/LhCLmEimKRg" height="1" width="1" alt=""/>]]></content:encoded>
      </item>
      <item>
         <title>Pedal the Cause: Team SBP pedals for Luke</title>
         <link>http://beaker.sbpdiscovery.org/2015/09/pedal-the-cause-team-sbp-pedals-for-luke/</link>
         <guid isPermaLink="false">http://beaker.sbpdiscovery.org/?p=42949</guid>
         <pubDate>Fri, 18 Sep 2015 20:17:21 +0000</pubDate>
         <content:encoded><![CDATA[<img width="564" height="377" src="http://beaker.sbpdiscovery.org/wp-content/uploads/2015/09/Luke-and-Team-SBP-at-Birch-Aquarium-4091.jpg" class="attachment-feed-four-story wp-post-image" alt="Luke Sybert tours the Birch Aquarium with SBP&#039;s Pedal the Cause team"/>Luke Sybert is a cancer patient at Rady Children's Hospital.  Team SBP is riding for Luke in the 2015 Pedal the Cause event.]]></content:encoded>
      </item>
      <item>
         <title>West Coast Bio Roundup: Google/Insel, SeaGen, Avalon, Alector &amp; More</title>
         <link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/23EPhxtEH2E/</link>
         <guid isPermaLink="false">http://www.xconomy.com/?p=309321</guid>
         <pubDate>Fri, 18 Sep 2015 11:31:40 +0000</pubDate>
         <content:encoded><![CDATA[It&#8217;s not specific to the West Coast, but anyone who needs to catch up on the week&#8217;s events should read the British Medical Journal&#8217;s re-analysis of a long-criticized study, dubbed...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/23EPhxtEH2E" height="1" width="1" alt=""/>]]></content:encoded>
      </item>
      <item>
         <title>Reality Check: Cancer Experts Discuss Hurdles Facing CAR-T Therapy</title>
         <link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/v7wU--cdDv8/</link>
         <guid isPermaLink="false">http://www.xconomy.com/?p=309310</guid>
         <pubDate>Fri, 18 Sep 2015 10:00:42 +0000</pubDate>
         <content:encoded><![CDATA[There’s a lot of excitement these days about a type of cellular immunotherapy known as CAR-T, a method of modifying peoples’ immune cells to fight cancer. But you could also fill a book listing all...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/v7wU--cdDv8" height="1" width="1" alt=""/>]]></content:encoded>
      </item>
      <item>
         <title>Alector Raises $32M For Immune-Based Neuro Drug Development</title>
         <link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/HwYQ2FnQ4VE/</link>
         <guid isPermaLink="false">http://www.xconomy.com/?p=309213</guid>
         <pubDate>Wed, 16 Sep 2015 22:05:38 +0000</pubDate>
         <content:encoded><![CDATA[Researchers around the world have explored the ties between the immune system and devastating neurodegenerative diseases such as Alzheimer&#8217;s. San Francisco biotech Alector wants to exploit...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/HwYQ2FnQ4VE" height="1" width="1" alt=""/>]]></content:encoded>
      </item>
      <item>
         <title>With Revamped Trial, Aerie, Glaucoma Drug Bounce Back</title>
         <link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/P_wgttBTCe8/</link>
         <guid isPermaLink="false">http://www.xconomy.com/?p=309199</guid>
         <pubDate>Wed, 16 Sep 2015 21:56:01 +0000</pubDate>
         <content:encoded><![CDATA[Aerie Pharmaceuticals took a beating from investors earlier this year when its glaucoma drug failed the first of a few Phase 3 trials. But today the company has bounced back, thanks to a helping hand...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/P_wgttBTCe8" height="1" width="1" alt=""/>]]></content:encoded>
      </item>
      <item>
         <title>Obama Nominates Duke Veteran Rob Califf To Lead FDA</title>
         <link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/YkWEe0Nha_Q/</link>
         <guid isPermaLink="false">http://www.xconomy.com/?p=309074</guid>
         <pubDate>Tue, 15 Sep 2015 23:38:38 +0000</pubDate>
         <content:encoded><![CDATA[President Obama has nominated cardiologist Rob Califf to be the next head of the Food and Drug Administration, replacing the outgoing Margaret &#8220;Peggy&#8221; Hamburg. The nomination is no...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/YkWEe0Nha_Q" height="1" width="1" alt=""/>]]></content:encoded>
      </item>
      <item>
         <title>American Copycats: Can Biosimilars Catch On And Cut Costs In U.S.?</title>
         <link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/sM4FMPFQ564/</link>
         <guid isPermaLink="false">http://www.xconomy.com/?p=308992</guid>
         <pubDate>Tue, 15 Sep 2015 10:30:11 +0000</pubDate>
         <content:encoded><![CDATA[Americans need to spend less on healthcare. Anyone disagree? No country spends like we do: 17 percent of our gross domestic product the past four years, in fact, according to the World Bank. No other...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/sM4FMPFQ564" height="1" width="1" alt=""/>]]></content:encoded>
      </item>
      <item>
         <title>Qualcomm Buys Capsule to Unite Health Data Across Hospital &amp; Home</title>
         <link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/yL92JYAasSY/</link>
         <guid isPermaLink="false">http://www.xconomy.com/?p=308983</guid>
         <pubDate>Mon, 14 Sep 2015 22:39:13 +0000</pubDate>
         <content:encoded><![CDATA[Qualcomm (NASDAQ: QCOM) said its Qualcomm Life subsidiary has acquired Capsule Technologie, an Andover, MA-based healthtech systems company with more than 1,900 hospital customers in 38 countries....<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/yL92JYAasSY" height="1" width="1" alt=""/>]]></content:encoded>
      </item>
      <item>
         <title>Pharma Plays The “Value” Card: Drug Spending Then And Now</title>
         <link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/prqv816GxZ4/</link>
         <guid isPermaLink="false">http://www.xconomy.com/?p=308744</guid>
         <pubDate>Mon, 14 Sep 2015 04:01:15 +0000</pubDate>
         <content:encoded><![CDATA[Dr. John Lechleiter, the CEO of Eli Lilly, recently attempted to debunk five “Big Myths” about Big Pharma. As he wrote, “Only about 10 cents of every U.S. healthcare dollar is spent on retail...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/prqv816GxZ4" height="1" width="1" alt=""/>]]></content:encoded>
      </item>
      <item>
         <title>West Coast Biotech Roundup: Tandem, Pathway Genomics, Denali &amp; More</title>
         <link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/zHqT95xOMNE/</link>
         <guid isPermaLink="false">http://www.xconomy.com/?p=308700</guid>
         <pubDate>Thu, 10 Sep 2015 11:40:21 +0000</pubDate>
         <content:encoded><![CDATA[Now that Labor Day is over, the innovation-driven life sciences editors at Xconomy can pass along the really important news&#8212;Billboard magazine’s final Songs of the Summer chart. As you may...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/zHqT95xOMNE" height="1" width="1" alt=""/>]]></content:encoded>
      </item>
      <item>
         <title>Antibody Maker AnaptysBio Joins IPO Queue With $86M In Its Sights</title>
         <link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/qbY5NWkDyRk/</link>
         <guid isPermaLink="false">http://www.xconomy.com/?p=308694</guid>
         <pubDate>Wed, 09 Sep 2015 23:35:08 +0000</pubDate>
         <content:encoded><![CDATA[San Diego-based AnaptysBio, a developer of antibody-based drugs, has placed a stake in the ground to go public, filing IPO paperwork Wednesday. The 10-year-old firm recently raised a $40 million...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/qbY5NWkDyRk" height="1" width="1" alt=""/>]]></content:encoded>
      </item>
      <item>
         <title>Biogen Pays $60M to Take on Celgene With a Rival Autoimmune Drug</title>
         <link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/z6dMlZdbGDU/</link>
         <guid isPermaLink="false">http://www.xconomy.com/?p=308629</guid>
         <pubDate>Wed, 09 Sep 2015 12:11:58 +0000</pubDate>
         <content:encoded><![CDATA[It’s unclear if Biogen was one of the unnamed bidders that lost out on Receptos a few months ago. But a deal the Cambridge-based company made this morning for a drug that would directly compete with...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/z6dMlZdbGDU" height="1" width="1" alt=""/>]]></content:encoded>
      </item>
      <item>
         <title>New Technique for Wearable Sensors Transmits Signal Through Body</title>
         <link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/Sf5ksISM-2o/</link>
         <guid isPermaLink="false">http://www.xconomy.com/?p=308487</guid>
         <pubDate>Tue, 08 Sep 2015 09:40:22 +0000</pubDate>
         <content:encoded><![CDATA[Electrical engineers at UC San Diego have reported a new wireless communication technique that uses magnetic fields to transmit ultra low-power signals through the human body. At a time when...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/Sf5ksISM-2o" height="1" width="1" alt=""/>]]></content:encoded>
      </item>
      <item>
         <title>West Coast Biotech Roundup: Amgen, Grizzlies, Topol, Faraday &amp; More</title>
         <link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/MOFbOj6BNKQ/</link>
         <guid isPermaLink="false">http://www.xconomy.com/?p=308392</guid>
         <pubDate>Thu, 03 Sep 2015 23:25:13 +0000</pubDate>
         <content:encoded><![CDATA[As biotech ended its worst market month since the recession, it was fitting that one of the week&#8217;s best stories was about bears. Grizzlies, to be precise. Grizzlies are oh-so-Western, so of...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/MOFbOj6BNKQ" height="1" width="1" alt=""/>]]></content:encoded>
      </item>
      <item>
         <title>Acadia, Under New CEO, Seeks Approval for Parkinson’s Drug</title>
         <link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/91aLuadTeIg/</link>
         <guid isPermaLink="false">http://www.xconomy.com/?p=308383</guid>
         <pubDate>Thu, 03 Sep 2015 18:47:25 +0000</pubDate>
         <content:encoded><![CDATA[San Diego’s Acadia Pharmaceuticals (NASDAQ: ACAD) said today it has submitted its lead drug candidate for FDA approval. The company also said Steve Davis, who became interim CEO in March, will...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/91aLuadTeIg" height="1" width="1" alt=""/>]]></content:encoded>
      </item>
      <item>
         <title>Scripps Enrolls 4,000+ in Scanadu Trial of Device for Vital Signs</title>
         <link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/BMClLb3rVgM/</link>
         <guid isPermaLink="false">http://www.xconomy.com/?p=308346</guid>
         <pubDate>Thu, 03 Sep 2015 15:13:15 +0000</pubDate>
         <content:encoded><![CDATA[In the five years since it was founded, Mountain View, CA-based Scanadu has been blessed with a groundswell of support from some pretty diverse groups&#8212;ordinary folks, elite investors, Web...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/BMClLb3rVgM" height="1" width="1" alt=""/>]]></content:encoded>
      </item>
      <item>
         <title>Pathway that controls cancer cell proliferation discovered</title>
         <link>http://beaker.sbpdiscovery.org/2015/08/scientists-discover-a-pathway-that-controls-cancer-cell-proliferation-by-nutrients/</link>
         <guid isPermaLink="false">http://beaker.sbpdiscovery.org/?p=42805</guid>
         <pubDate>Thu, 13 Aug 2015 16:12:01 +0000</pubDate>
         <content:encoded><![CDATA[<img width="564" height="318" src="http://beaker.sbpdiscovery.org/wp-content/uploads/2015/08/diaz-meco-mtor-beaker.jpg" class="attachment-feed-four-story wp-post-image" alt="New molecular cascade to sense nutrients in cancer"/>Study reveals new drug targets to selectively inhibit a key event in tumor-cell progression.]]></content:encoded>
      </item>
      <item>
         <title>SBP Graduate School of Biomedical Sciences receives WASC accreditation</title>
         <link>http://beaker.sbpdiscovery.org/2015/07/sbp-graduate-school-of-biomedical-discovery-receives-wasc-accreditation/</link>
         <guid isPermaLink="false">http://beaker.sbpdiscovery.org/?p=42756</guid>
         <pubDate>Thu, 30 Jul 2015 17:59:14 +0000</pubDate>
         <content:encoded><![CDATA[<img width="564" height="318" src="http://beaker.sbpdiscovery.org/wp-content/uploads/2015/07/grad-school-WASC-beaker.jpg" class="attachment-feed-four-story wp-post-image" alt="SBP congratulates the Graduate School of Biomedical Sciences"/>SBP's Graduate School of Biomedical Sciences has received WASC accreditation, recognizing excellence in academic and technical training in the fields of biology, chemistry, bioinformatics, and engineering.]]></content:encoded>
      </item>
      <item>
         <title>Researchers find new method to halt the advance of liver cancer</title>
         <link>http://beaker.sbpdiscovery.org/2015/07/researchers-find-new-method-to-halt-the-advance-of-liver-cancer/</link>
         <guid isPermaLink="false">http://beaker.sbpdiscovery.org/?p=42758</guid>
         <pubDate>Fri, 24 Jul 2015 13:00:52 +0000</pubDate>
         <content:encoded><![CDATA[<img width="640" height="496" src="http://beaker.sbpdiscovery.org/wp-content/uploads/2015/07/Cholangiocarcinoma.jpg" class="attachment-feed-four-story wp-post-image" alt="Cholangiocarinoma is a type of liver cancer that is considered to be an incurable and rapidly lethal malignancy"/>Liver cancer is the third leading cause of cancer-related deaths worldwide. New research indicates that blocking the activity of the lymphotoxin-beta receptor may improve the outcome of for patients with this disease.]]></content:encoded>
      </item>
   </channel>
</rss>
<!-- fe8.yql.bf1.yahoo.com compressed/chunked Thu Oct  1 22:39:02 UTC 2015 -->
